High Court Mulls Taking Up Diagnostic Patent Eligibility Fight

On February 26, 2021, Dr. MaryAnne Armstrong was quoted in a Bloomberg Law article discussing Ariosa’s appeal to the Supreme Court of a Federal Circuit decision reviving Illumina Inc.'s fetal DNA test patents and what the outcome could mean for patent eligibility in the biotech industry. Read the full article here.